Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
Scientific and practical peer-reviewed journal for cardiologists and general practice physicians. Issued since 2005
ISSN 1819-6446 (Print) ISSN 2225-3653 (Online)
The use of angiotensin converting enzyme inhibitors after myocardial infarction. What do evidence-based medicine data speak for?
S.Yu. Martsevich*
State Research Center for Preventive Medicine. Petroverigsky per. 10, Moscow, 101990 Russia
I.M. Sechenov First Moscow State Medical University. Trubetskaya ul. 8/2, Moscow, 119991 Russia
The main trails proven angiotensin converting enzyme (ACE) inhibitor effects on the life prognosis after myocardial infarction (MI) are described. Different tactics of ACE inhibitors therapy in post MI patients are presented. Approaches to the choice of a specific ACE inhibitor are discussed.
Key words: randomized clinical trials, angiotensin converting enzyme inhibitor, myocardial infarction.
Rational Pharmacother. Card. 2010;6(5):673-676
*Corresponding author: smartsevich@gnicpm.ruDownload free full text (PDF)
© 2007 — 2014 «Rational Pharmacotherapy in Cardiology»
«Stolichnaya Izdatelskaya Kompaniya»
ISSN 1819-6446(Print) ISSN 2225-3653 (Online)
«Stolichnaya Izdatelskaya Kompaniya»
ISSN 1819-6446(Print) ISSN 2225-3653 (Online)